Data protection Impressum

Pharma

Swissmedic, Switzerland's national regulatory authority for therapeutic products, has strengthened its role in the global healthcare landscape through strategic collaborations and innovations in regulatory science. From cross-border initiatives to advances in digital transformation, Swissmedic is positioning itself as a leader in efficient, high-quality regulatory processes, providing Swiss patients with safe and timely access to cutting-edge therapies.

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics

11 November 2024

Ikerian has raised USD 8 million in Series B funding to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics. Lead investor Sanoptis has entered a strategic partnership to distribute the platform across its European network.

Ikerian secures USD 8 million and a strategic partnership with Sanoptis

29 October 2024

Three Geneva-based start-ups - Dyneo Technologies, Adoram Therapeutics and ex vivo - have received CHF 250,000 from the FONGIT Innovation Fund to advance solutions in cleantech, life sciences and virtual reality.

Three innovative Geneva-based start-ups receive FIF funding

28 October 2024

Certification Experts, a division of Kader Group, has opened a new office on Lausanne's Biopôle campus, reinforcing its presence in Switzerland to meet rising demand for compliance and regulatory consulting in the medical device and pharmaceutical sectors.

Certification Experts expands medtech services with new office at Biopôle

28 October 2024

Lonza expands its collaboration with a major biopharma partner, adding a new bioconjugation suite in Visp to support advanced cancer therapy manufacturing.

Lonza expands its manufacturing capabilities in Visp and creates 100 new jobs

23 October 2024

Nestled in the quiet industrial zone of Domdidier, in the canton of Fribourg, Medistri has grown into a key player in the highly specialized field of sterilization for medical and pharmaceutical industries.

Medistri, Fribourg’s hidden champion in medtech and pharmaceutical sterilization

22 October 2024

Phoenix Pharma Switzerland has announced the relocation of its Swiss headquarters to the Businesspark Liebefeld in Köniz, bringing 100 new jobs to the canton of Bern.

Phoenix Pharma Switzerland relocates its headquarters to the canton of Bern

2 October 2024

A Memorandum of Understanding (MOU) between KoreaBIO and the Switzerland Innovation Park West EPFL was signed during the Korea-Switzerland Partnering Day, strengthening industrial cooperation and joint research in biotech.

Switzerland strengthens biotech collaboration with KoreaBIO through new MOU

30 September 2024

ten23 health celebrates the opening of its VIVA2® facility in Visp, increasing the region's sterile pharmaceutical production capacity and strengthening its position in the life sciences sector.

ten23 health inaugurates VIVA2 sterile production facility in Visp

24 September 2024

HAYA Therapeutics has announced a multi-year collaboration with Eli Lilly, potentially earning up to USD 1 billion in milestone payments to advance RNA-guided therapies for obesity and metabolic disorders.

HAYA Therapteutics enters major collaboration to advance RNA-based drug discovery

17 September 2024

1 2 3 4 5 6 … 13